Conjugation Chemistry: Antibody–Fluorophore Coupling¶
The detection signal in a FICT assay is generated by a fluorescent label conjugated to a detection antibody. How that conjugation is performed — the chemistry, the ratio, and the removal of free label — directly determines assay sensitivity and background. This page documents the conjugation approaches used in Migibio manufacturing.
The Conjugation Goal¶
For every antibody molecule on the conjugate pad, we want:
- A controlled number of fluorescent labels bound (the conjugation ratio).
- Labels bound at sites that do not block the antigen-binding (paratope) region.
- Minimal free (unbound) label, which raises background.
Conjugation Chemistries¶
| Chemistry | Mechanism | Used for |
|---|---|---|
| Carbodiimide (EDC/NHS) | Covalent amide bond between carboxyl groups and antibody amines | Carboxylated fluorescent microspheres |
| Physical adsorption | Hydrophobic / electrostatic binding | Passive coating (limited) |
| Biotin–streptavidin | High-affinity non-covalent linkage | Oriented, controlled coupling |
Carbodiimide (EDC/NHS) Coupling¶
This is the workhorse for carboxylated microspheres:
- Activation — EDC/NHS activate the surface carboxyl groups to amine-reactive esters.
- Coupling — the antibody's primary amines form covalent amide bonds.
- Quenching/blocking — unreacted sites are blocked to reduce non-specific binding.
- Washing — free (unbound) antibody and label are removed.
The result is a stable covalent conjugate with a tunable antibody-to-particle ratio.
Biotin–Streptavidin Coupling¶
Biotinylated antibody + streptavidin-coated label gives a near-covalent (femtomolar affinity) linkage with controlled orientation — useful when paratope accessibility must be preserved.
Conjugation Ratio Optimization¶
The antibody-to-label ratio is a critical tunable parameter:
| Ratio | Effect |
|---|---|
| Too low | Weak signal, poor sensitivity |
| Too high | Steric hindrance, aggregation, high background |
| Optimal | Maximum signal with minimal non-specific binding |
The optimal ratio is determined empirically during assay development and locked as a manufacturing specification.
Quality Control of Conjugation¶
| Check | Method | Acceptance |
|---|---|---|
| Coupling efficiency | Measure free vs. bound label | ≥ defined threshold |
| Aggregation | Particle-size analysis | No significant aggregation |
| Functional activity | Binding assay vs. reference conjugate | Within specified range |
| Lot consistency | Compare to reference conjugate | Pass lot-release criteria |
Impact on Assay Performance¶
- Sensitivity (LOD): higher coupling efficiency → stronger signal per analyte molecule → lower LOD.
- Background: free label and aggregation are the dominant background contributors.
- Precision (CV%): uniform conjugation across a lot reduces signal variance.
FAQ¶
Why is conjugation done in-house? Conjugation is the single most performance-defining step; controlling it in-house is what enables tight lot-to-lot consistency and OEM customization.
Does conjugation chemistry differ between assays? Yes — the label type and coupling chemistry are optimized per analyte during development.
For the manufacturing workflow that uses these conjugates, see the Knowledge Base.
Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.
Reviewed by: Migibio R&D Quality Committee
Last updated: 2026-08-14
Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.